GnRH antagonist in assisted reproduction: a Cochrane review.
about
Optimal usage of the GnRH antagonists: a review of the literatureThe effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSSMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.Predictive factors for recovery time in patients suffering from severe OHSS.Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocolThe correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles.The efficacy of recombinant versus urinary HCG in ART outcome.Comparison of ovulation induction protocols after endometrioma resection.Cetrorelix in the treatment of female infertility and endometriosis.Cessation of gonadotropin-releasing hormone antagonist on triggering day: an alternative method for flexible multiple-dose protocolGnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.Safety of GnRH agonists and antagonists.Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran.Emerging drugs in assisted reproduction.New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists.Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocolThe effects of GnRH antagonist on the endometrium of normally menstruating women.Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles.Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis.The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome.Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol.Cessation of gonadotropin-releasing hormone antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study.Gonadotropin-releasing hormone in the ovary.Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes.Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm InjectionIVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation.A comparative study on the results of agonist and antagonist protocols based on serum AMH levels in patients undergoing intracytoplasmic sperm injection.The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study.Agonist or antagonist: what is preferable for in vitro fertilization?Clinical efficacy of the gonadotropin-releasing hormone antagonist, ganirelix, in Korean women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer with recombinant follicle-stimulating hormone.Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.Overview of elagolix for the treatment of endometriosis.
P2860
Q21245566-4B4F3A30-71FD-4587-8CCA-E9AA4C2C3B08Q28831013-373D0AF7-A27A-4BAC-BBEC-16EE2257985AQ30399747-451B2E73-B776-4A26-B81D-C82A04A6F29AQ33896594-F20EDDAD-B837-4AF3-80DA-DCAD06BACC4AQ34173433-A99CB83F-840A-41D1-945A-87A10A454150Q34196524-B8A3D171-03C3-4621-ACEA-DAE65F0EC046Q34216481-A7CA7FF0-45DC-4CF9-9B16-D2292BE7EF9CQ34217528-23BC7FD8-73A8-47FD-8B2B-8B996405478CQ34401295-6F15038B-068C-41C9-97CA-E279F52B4776Q34571550-72A9711A-A737-4E23-A559-9F2C11DB2F8EQ34607007-C9BA365F-BBE0-43EE-BA18-B8641450B510Q34636679-113701C3-BFAC-4481-8807-2348BC2A98CEQ35123968-106279E7-F3F9-4139-94C4-80D3FEA821D7Q35609748-CB65C3E2-BDE3-4B7F-84B9-F4C5D6A07CC5Q35808082-B3DD1710-1E83-4797-90AA-BDD134F90562Q36074736-8E364EEA-A586-4393-92AD-62FC30D95127Q36150659-B4398264-2A4F-4380-B982-0C257351B980Q36249876-1DB9DECA-C21D-42D2-9A39-D70B6E35769EQ36268229-5C0C8AD3-4E4C-4C9F-A119-079DDC18E860Q36268361-13E684B1-1FDD-4998-AA09-488A585CEE99Q36268633-05B2FB58-4830-4FF7-87F9-A5BC2C94BD79Q36423212-A8C5C53A-939D-49F7-B658-4F8B637C1EF8Q36423226-5FB4BB98-B3DD-486F-B7BD-4012C3447AE1Q36571890-34D922AB-1635-42F9-AEEB-915A49769D2DQ36970286-94199D0C-2493-45E2-9F12-CA226D71844CQ36984419-B42EFB8A-51AF-48A2-8308-EDB7D2648825Q37022407-F11D71ED-CBD1-4DCE-88DC-12C80007CE77Q37035786-C679773E-67BE-479C-9C88-551D3D1F8077Q37077680-E309DB7C-2474-4069-8339-4E318FF68D9CQ37099563-5F5B3510-5E04-4512-80F9-C55B366D2829Q37126409-B6F6E85C-373B-4DD6-911C-CC0C15CA5312Q37429879-DC4DEF2F-AB60-4DB5-AA11-597866B9623DQ37547081-DBE326EC-9E76-410C-AA8C-3449ADBE42B1Q37561727-F061C1B1-E3A9-4A96-B0CB-40969C5E328DQ37598922-90BE51CD-0DAC-4892-A914-5716584A35A0Q37611176-10074420-A520-4D1B-9404-CE8EBE36F166Q37990999-F06C671D-E5E0-459D-A9E8-3A230110CA80Q38514150-6A09C979-E828-4447-A18E-C3DCCCFD347CQ38590592-B9991F84-8138-4475-90D9-701B4A5C9D62Q38791644-1DF45D9F-399D-46F3-8FDD-897EA7447BB0
P2860
GnRH antagonist in assisted reproduction: a Cochrane review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
GnRH antagonist in assisted reproduction: a Cochrane review.
@ast
GnRH antagonist in assisted reproduction: a Cochrane review.
@en
GnRH antagonist in assisted reproduction: a Cochrane review.
@nl
type
label
GnRH antagonist in assisted reproduction: a Cochrane review.
@ast
GnRH antagonist in assisted reproduction: a Cochrane review.
@en
GnRH antagonist in assisted reproduction: a Cochrane review.
@nl
prefLabel
GnRH antagonist in assisted reproduction: a Cochrane review.
@ast
GnRH antagonist in assisted reproduction: a Cochrane review.
@en
GnRH antagonist in assisted reproduction: a Cochrane review.
@nl
P356
P1433
P1476
GnRH antagonist in assisted reproduction: a Cochrane review.
@en
P2093
Hesham Al-Inany
Mohamed Aboulghar
P304
P356
10.1093/HUMREP/17.4.874
P407
P577
2002-04-01T00:00:00Z